TBBA (TBBA) Stock Price & Analysis
TBBA (TBBA) rose 10.07% to USD 7.98 as of July 25, 2026 at 06:13 UTC, according to Nexqual real-time market data.
TBBA last closed at USD 7.25; the session ranged USD 7.5–7.5 on volume of 100 shares. Market capitalization is $20.94M, with a 52-week range of USD 5.6–9 (OID). Source: Nexqual, July 25, 2026 at 06:13 UTC.
Key Statistics (as of July 25, 2026 at 06:13 UTC)
| Price | USD 7.98 |
|---|---|
| Change | ▲ 10.07% (up) |
| Previous Close | USD 7.25 |
| Open | USD 7.5 |
| Day Range | USD 7.5 – 7.5 |
| 52-Week Range | USD 5.6 – 9 |
| Volume | 100 shares |
| Market Cap | $20.94M |
| Exchange | OID |
Technical Analysis (TBBA)
Nexqual's technical model rates TBBA "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 06:13 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 75.78 (overbought) |
| vs SMA50 | Above (USD 6.66) |
| MACD | 0.23 (positive) |
Analyst Ratings (TBBA)
Wall Street analysts rate TBBA "None", per Nexqual as of July 25, 2026 at 06:13 UTC.
| Consensus Rating | None |
|---|
Earnings (TBBA)
Source: Nexqual, July 25, 2026 at 06:13 UTC.
Financials & Fundamentals (TBBA)
| Total Revenue | $10.45M |
|---|---|
| Revenue Growth (YoY) | -38.80% |
| Gross Margin | +0.00% |
| Operating Margin | +14.67% |
| Profit Margin | -12.56% |
| ROE | -4.62% |
| Total Cash | $26.04M |
| Total Debt | $5.00M |
Source: Nexqual, July 25, 2026 at 06:13 UTC.
Financial Health Score (TBBA)
Nexqual rates TBBA's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:13 UTC.
| Growth | Critical — Revenue -39% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $26M cash vs $5M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Critical — ROE -5%, ROA -0.4% |
Ownership (TBBA)
| Insider Ownership | +52.51% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.62M |
Source: Nexqual, July 25, 2026 at 06:13 UTC.
Leadership (TBBA)
TBBA is led by Thomas Sattler (age 60), President, CEO & Director, per Nexqual as of July 25, 2026 at 06:13 UTC.
| President, CEO & Director | Thomas Sattler (age 60) |
|---|---|
| Chief Financial Officer | John P. Udvare (age 60) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| BRSF | BRAIN SCIENTIFIC INC | USD 0 | ▲ 0% |
| QNTO | Quaint Oak Bancorp, Inc. | USD 14.2 | ▲ 0% |
| FRSB | FIRST RESOURCE BANCORP INC. | USD 25.76 | ▲ 3.04% |
| FFMH | First Farmers & Merchants Corp. | USD 59 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:13 UTC. This page is informational and not investment advice.